UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D. C. 20549

                  ----------------------------

                           FORM 10-QSB

                  ---------------------------

(X)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES
     EXCHANGE ACT OF 1934

     For the quarter ended March 31, 2003



( )  TRANSITION REPORT PERSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934

   For the transition period from  ___________ to ___________

                Commission File Number:  0-49655



                     ANTICLINE URANIUM, INC.
                     -----------------------
(Exact name of small business issuer as specified in its charter)


       NEVADA                                  87-0678927
       ------                                  ----------
 (State of incorporation)               (I.R.S. EMPLOYER ID NO.)



              3098 South Highland Drive, Suite 323
     Salt Lake City, Utah                         84106-6001
     -------------------------------------------------------
   (Address of principal executive offices)         (Zip Code)


                         (801) 467-2021
                         --------------
        (Issuer's telephone number, including area code)


     Indicate the number of shares outstanding of each of the
Issuer's classes of common stock, as of the latest practicable date.

     Class                       Outstanding as of May 14, 2003
------------------            -----------------------------------

Common Capital Voting Stock,            5,713,112 shares
$0.001 par value per share


                   FORWARD-LOOKING STATEMENTS

This third Quarterly Report on Form 10-QSB, Financial Statements
and Notes to Financial Statements contain forward looking-
statements.   All statements made in this Report or in another
Report incorporated by reference that are not statements of
historical fact are forward-looking statements.  We caution the
reader not to place undue reliance on any forward-looking
statements, which speak only as of the date of the respective
Reports.   Important factors could cause actual results to differ
from those expressed in the forward-looking statements.


                                        1

                 PART 1 - FINANCIAL INFORMATION

Item 1.  Financial Statements.


ANTICLINE URANIUM, INC.
CONDENSED BALANCE SHEETS
(UNAUDITED)

<TABLE>
<CAPTION>

                                                             March 31,   December 31,
ASSETS                                                         2003           2002
-------------------------------------------------------------------------------------


                                                      <c>                <c>
Current Assets
Cash                                                      $         18       $      -
-------------------------------------------------------------------------------------

Total Current Assets                                                18              -

Total Assets                                              $         18       $      -
=====================================================================================
LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
Accrued liabilities                                          $  33,764       $ 26,441
Advance from related party                                       7,325          6,075
-------------------------------------------------------------------------------------

Total Current Liabilities                                       41,089         32,516
-------------------------------------------------------------------------------------

Long-Term Liabilities
Notes payable                                                   20,000         20,000
Notes payable - related parties                                 30,000         30,000
-------------------------------------------------------------------------------------

Total Long-Term Liabilities                                     50,000         50,000
-------------------------------------------------------------------------------------

Commitments and Contingencies - Note 9

Stockholders' Deficit
Common stock - $0.001 par value; 50,000,000 shares
authorized; 5,713,112 shares issued and outstanding              5,713          5,713
Additional paid-in capital                                     665,977        665,977
Deficit accumulated prior to inception of the exploration     (703,013)      (703,013)
Deficit accumulated during the exploration stage               (59,748)       (51,193)
-------------------------------------------------------------------------------------

Total Stockholders' Deficit                                    (91,071)       (82,516)
-------------------------------------------------------------------------------------

Total Liabilities and Stockholders' Deficit               $      18       $      -
=====================================================================================



</TABLE>

See the notes to the unaudited condensed financial statements.

                                        2


ANTICLINE URANIUM, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)

<TABLE>
<CAPTION>
                                                                                     For the Period
                                                                                    from August 10,
                                                                                      2001 (Date of
                                                                                     Inception of the
                                                     For the Three Months Ended     Exploration Stage)
                                                              March 31,                 through
                                                     --------------------------        March 31,
                                                         2003            2002            2003
-----------------------------------------------------------------------------------------------------


                                                 <c>            <c>             <c>

General and Administrative Expenses                  $  (7,672)     $   (4,441)     $ (54,572)

Interest Expense                                          (883)           (862)        (6,099)

Other Income                                                 -              12            923
---------------------------------------------------------------------------------------------

Net Loss                                             $  (8,555)     $   (5,291)     $ (59,748)
=============================================================================================

Basic Loss Per Common Share                          $       -      $        -
------------------------------------------------------------------------------

Weighted-Average Common Shares Outstanding           5,713,112       5,213,112
------------------------------------------------------------------------------


</TABLE>

See the notes to the unaudited condensed financial statements.

                                        3


ANTICLINE URANIUM, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)

<TABLE>
<CAPTION>

                                                                               For the Period
                                                                              from August 10,
                                                                              2001 (Date of
                                                                              Inception of the
                                                 For the Three Months Ended  Exploration Stage)
                                                       March 31,                 through
                                                 --------------------------     March 31,
                                                    2003           2002           2003
-----------------------------------------------------------------------------------------------

                                             <c>            <c>            <c>
Cash Flows From Operating Activities
Net loss                                         $ (8,555)      $ (5,291)      $ (59,748)
Adjustments to reconcile net loss to net c
  ash used by operating activities:
Stock issued for services                               -              -           5,000
Contributed services                                    -              -             525
Changes in operating assets and liabilities:
Accrued liabilities                                 7,323            862          (3,084)
-----------------------------------------------------------------------------------------------

Net Cash Used in Operating Activities              (1,232)        (4,429)        (57,307)
-----------------------------------------------------------------------------------------------

Cash Flows From Financing Activities
Proceeds from notes payable from related party          -              -          50,000
Proceeds from advance from related party            1,250              -           7,325
-----------------------------------------------------------------------------------------------

Net Cash Provided by Financing Activities           1,250              -          57,325
-----------------------------------------------------------------------------------------------

Net Increase (Decrease) in Cash                        18         (4,429)             18

Cash at Beginning of Period                             -          6,667               -
-----------------------------------------------------------------------------------------------

Cash at End of Period                            $     18       $  2,238       $      18
===============================================================================================



</TABLE>

See the notes to the unaudited condensed financial statements.

                                        4



                     ANTICLINE URANIUM, INC.
            NOTES TO CONDENSED FINANCIAL STATEMENTS
                          (UNAUDITED)

NOTE 1 - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

In  1974,  North Beck Joint Venture LLC, a Utah limited  liability company
("North Beck"), acquired certain patented  mining  claims comprising 470 acres
located in the Tintic Mining District of Juab County,  Utah  (the  "Mining
Claims")  for  $134,000.  North  Beck charged  the acquisition costs of the
mining claims to  operations as  exploration  costs  at the time of the
purchase.   North  Beck leased the Mining Claims to an unrelated mining company
from  1985 through  1998  for approximately $30,000 that was paid  over  five
years.  From  1998 until August 10, 2001, North Beck  had  minimal operations
that  consisted of maintaining its  legal  status  and leasing the surface
rights of the Mining Claims under the terms of a small grazing lease.

Anticline  Uranium,  Inc. ("Anticline") was  incorporated  in  the State   of
California  on  October  19,  1954.   Anticline was incorporated for the purpose
of exploring, prospecting for, mining and treating uranium and other minerals in
Utah and to acquire and sell  mineral estates including oil and gas properties
and rights. In  1955,  Anticline completed a public offering of  its  Class  A
common shares, designated to be issued to the public, for $282,000 and   issued
Class  B  common  shares,  designated  as  incentive compensation, for services.
The proceeds from the public  offering were  used  for  incorporation  expenses,
exploration  of  mining claims,  equipment and payment of wages. Anticline
became inactive shortly after its public offering and remained dormant until
June 29,  2001, when it was reactivated and received proceeds from  the issuance
of  notes payable. Anticline used the  proceeds  of  its notes  payable  to  pay
back taxes to  the  State  of  California Franchise Tax Board in order to
reinstate its corporate charter.

Anticline held a court-ordered shareholders' meeting on  July  26, 2001,  where,
by  order  of law, a new  board  of  directors  was elected. The Anticline
shareholders voted to consolidate the Class A  and Class B stock into one class
of common stock, to change the par  value  of  the stock from $0.10 to $0.001
per  share  and  to increase the authorized number of common shares to 50
million.  As a result of the shareholders' meeting, Anticline was controlled by
the owners of North Beck.

Anticline  changed its domicile, effective October 4,  2001,  from California
to  Nevada by merging with and  into  a  wholly  owned subsidiary that bears the
same name, with the Nevada entity  being the  surviving entity.  The Agreement
and Plan of Merger  approved by  the shareholders of both corporations provided
that the shares in  the  California corporation were exchanged for shares  in
the Nevada  corporation  on  a 1-for-100 basis.   The  stock-for-stock exchange
was  accounted  for  as  a  reverse  stock  split. The shareholders  later
approved  a  4-for-1  forward   stock   split effective  December 31, 2001.  The
net effect  of  the  two  stock splits is a 25-to-1 reverse stock split.  The
financial statements have  been  retroactively restated for the effects of  both
stock splits for all periods presented.

On  August 10, 2001, North Beck transferred 96.5% of the rights to the  Mining
Claims  to  Anticline, under the  terms  of  a  lease agreement (the "Mining
Lease"), for a period of five years  (North Beck  retained  a 3.5% net smelter
royalty on all mineral  bearing ores  sold)  in  exchange for Anticline's
issuance  of  5,000,000 common  shares  (95%  of  its outstanding common  stock)
and  for Anticline's  commitment and obligation to spend $15,000  over the five-
year  lease  term  in  exploration,  mining,  development  or incurring similar
costs for the benefit of the property subject to the Mining Lease.

The  Mining  Lease was between entities under common  control.  In accordance
with Statements of Financial Accounting Standards  No. 141,  "Business
Combinations," the Mining Lease and the  5,000,000 shares  of  common  stock
issued to North Beck  were  recorded  by Anticline at zero cost, which was the
historical carrying value to North  Beck  of  the  property subject to the
Mining  Lease.  The accompanying  financial  statements are presented  on  a
combined basis  and  include  the assets, liabilities, equity,  income  and
expenses  relating  to  the Mining Claims of  North  Beck  and  of Anticline
for all periods presented through August 10, 2001.  The financial  statements
present  the assets,  liabilities,  equity, income and expenses of Anticline
subsequent to August 10, 2001.

Interim   Financial   Statements  -  The  accompanying   unaudited condensed
financial  statements do not  include  all  disclosures normally  required by
accounting principles generally accepted  in the United States.  These
statements should be read in conjunction with  the  Company's annual financial
statements included  in  the Company's  December 31, 2002 Form 10-KSB filed on
April 11,  2003. In the opinion of management, all adjustments necessary for a
fair presentation  have  been  included in the  accompanying  condensed
financial   statements  and  consist  of  only  normal   recurring adjustments.
The  results  of  operations  presented  in the accompanying  unaudited
condensed financial  statements  for  the three  months ended March 31, 2003
are not necessarily  indicative of  the  results  that may be expected for the
full  year  ending December 31, 2003.

Use  of  Estimates  - The preparation of financial  statements  in conformity
with accounting principles generally accepted  in  the United States of America
requires management to make estimates and assumptions  that affect certain
reported amounts and  disclosures in  the  accompanying financial statements.
Actual  results  could differ from those estimates.

Basic Loss Per Share - Basic loss per common share is computed  by dividing net
loss by the weighted-average number of common  shares outstanding during the
period.  There were no potentially issuable common  shares.   Accordingly
diluted  loss  per  share  is not presented.

NOTE 2 - BUSINESS CONDITION

During the three months ended March 31, 2003, the Company incurred a  loss  of
$8,555  and  used cash from operating  activities  of $1,232.  The  Company  had
no  revenues  from  operations.  These conditions raise substantial doubt about
the Company's ability  to continue as a going concern.

The  Company's  continuation as a going concern is dependent  upon its  ability
to  generate  sufficient  cash  flows  to  meet  its obligations  on  a  timely
basis, to obtain financing  as  may  be required,  and  ultimately  to attain
profitable  operations.  The Company  plans  to raise the money or other capital
necessary  to explore  its  leased patented mining claims comprising  470  acres
located in the Tintic Mining District of Juab County, Utah.  There is  no
assurance that a commercially viable mineral deposit exists in  the mining lease
properties until sufficient exploration  work and  evaluation based upon such
work concludes economic and  legal feasibility. The Company plans to obtain
funding through issuances of  its common stock. However, there can be no
assurance that  the Company  will  be  successful in its efforts to explore  and
mine precious minerals from its Mining Lease, nor can there can be  any
assurance  that  the  necessary financing will  be  realized  from issuance  of
its  common stock, or that such  financing  will  be available on terms
favorable to the Company.

NOTE 3 - MINING LEASE

Under  the  terms of the Mining Lease, Anticline is  obligated  to spend
$15,000 over the 5-year lease term in exploration,  mining, development  or
incurring similar costs for the  benefit  of  the property subject to the Mining
Lease.  Any shortfall at the end of the  5-year lease period is due and payable
in cash to North Beck. North  Beck  also agreed to indemnify and hold Anticline
harmless from  any  Environmental Protection Agency claim or  claims  by  a
similar state agency based solely on past mining contaminations or other
environmental  violations  or  damage.   The  Mining  Lease contains  an  option
to  buy the property  from  North  Beck  for $3,000,000. The  Mining Lease
expires  on  August  9,  2006  and provides  Anticline with the option to renew
the lease  in  5-year renewals on substantially the same terms and conditions.


Anticline is obligated to pay a 3.5% net smelter royalty to  North Beck  on  all
mineral-bearing ores sold, which royalty is due  and payable 45 days after
payment is received from a smelter or buyer. The  Mining  Lease agreement also
gives a credit to Anticline  for the first $30,000 of net smelter royalties owed
to North Beck as a result of the 5,000,000 shares issued to North Beck.

NOTE 4 - ADVANCE FROM RELATED PARTY

An  officer  of the Company loaned the Company a total  of  $1,250 during  the
quarter  in order to pay general  and  administrative expenses  incurred during
the previous quarter.  As of  March  31, 2003,  such  officer has advanced the
Company a total  of  $7,325, nearly  all of which has been spent on accounting
fees  and  costs and transfer agency fees and costs incurred during 2002 and
within the  last  quarter.  During April 2002, such officer advanced  the
Company an additional $210.

NOTE 5--STOCK OPTIONS

During March 2003, the board of directors approved and adopted the "2003  Stock
Option/Stock  Issuance Plan"  (the  "Plan")  with  a maximum  of 1,500,000
shares of common stock reserved for issuance under  the  Plan.   The Board has
authorized options  to  purchase 500,000  common shares to be granted at a
purchase price of  $0.01 per share, but to date the Company has not granted any
options  to its  employees, officers or directors.  The Plan provides for both
the  direct  award  of  shares and for the  grant  of  options  to purchase
shares.  Under the Plan, the board  of  directors  shall determine which
eligible persons are to receive Incentive  Options or  Non-Statutory grants or
stock issuances in accordance with the Plan. The board of directors also set the
exercise price per share of  options granted. The option terms shall not exceed
ten  years from the option grant date.


Item 2.  Management's Discussion and Analysis or Plan of Operation

Anticline Uranium, Inc. ("Anticline" or "Company") is engaged in mineral
exploration.  The discussion hereunder is based on certain expectations
concerning the mining industry, the demand for precious metals, and the sources
and potential for obtaining financial capital, all of which involve "forward-
looking statements."  The Company does not intend to forecast what may or may
not occur in the future, nor will the Company predict that any particular event
may or may not occur.  Management emphasizes that it can neither control nor
predict many of these risks and uncertainties.

The Company has been in the process of reactivating itself and is now in the
position of determining what business opportunities are available to it,
including evaluating the possible future exploration of the patented mining
claims it has acquired by lease agreement ("the North Beck Claims").  Prior to
the filing of its registration statement on Form 10-SB on March 1, 2002, the
Company had been dormant and inactive.

Recent Events

On March 14, 2003, by unanimous written consent of the Company's directors, the
Company authorized the issuance of 500,000 shares of common stock to two
officers and directors in exchange for $5,000 worth of services rendered the
Company during 2002.  A copy of this written consent of directors is attached as
an exhibit to the Company's Annual Report on Form 10-KSB filed with the
Commission as recently as April 11, 2003.  These shares were authorized to be
issued at a value of one cent ($0.01) per share. The stock will not be
physically issued by the Company's transfer agent until the Company registers
the same with the Commission on a Form S-8 registration statement, something the
Company intends to do within the next two to four weeks.  Because the shares
were earned in 2002, the Company's year-end financial statements filed with its
Form 10-KSB treat these additional 500,000 shares as issued and outstanding as
of December 31, 2002.  Thus, the Company now has a total of 5,713,112 shares
issued and outstanding.

In the same written consent of directors, the board of directors approved and
adopted the "2003 Stock Option/Stock Issuance Plan" (the "Plan") with a maximum
of 1,500,000 shares of common stock reserved for issuance under the Plan.  The
Board has authorized options to purchase 500,000 common shares to be granted at
a purchase price of $0.01 per share, but to date the Company has not granted any
options to its employees, officers or directors.  The Plan provides for both the
direct award of shares and for the grant of options to purchase shares. Under
the Plan, the board of directors shall determine which eligible persons are to
receive Incentive Options or Non-Statutory grants or stock issuances in
accordance with the Plan. The board of directors also set the exercise price per
share of options granted. The option terms shall not exceed ten years from the
option grant date.

Plan of Operation

During the quarter ended March 31, 2003, Anticline did not conduct
any business activity that resulted in revenues.  All of its activities during
the quarter were devoted to further reactivating itself, preparing and filing
its Annual Report for 2002 on Form 10KSB, and otherwise further establishing a
business plan and plan
of operation.

The working capital of the Company at March 31, 2003, was essentially zero.
During the quarter, and in order to pay accounting and transfer agent fees and
expenses incurred during the previous quarter, the Company's president, John
Michael Coombs, advanced the Company a total of $1,250.  Since that date, Mr.
Coombs advanced the Company an additional $210 or a total of $1,460 since
January 1, 2003, nearly all of which has been used to pay accounting fees and
expenses.  At the moment, the Company owes its auditors approximately $2,500, a
figure that does not include the cost of the review necessary to file this
Quarterly Report.

Anticline will likely require additional financing to continue to develop its
business plan and to begin its implementation. Management believes this amount
may be substantial if Anticline chooses, or is otherwise able, to proceed with
the exploration of its leased mining property.  Anticline currently has no
sources of financing, including bank or private lending sources, or equity
capital sources.  No assurance can be given that Anticline will be able to
develop any sources of funding or financing in the future. To implement its
business plan and engage in the exploration of the North Beck Claims, Anticline
will need substantial additional funding.  Because these requirements are in the
more distant future, management has not yet begun to develop methods or plans of
financing.  If and when necessary, management expects that it will use equity,
debt and other arrangements such as joint ventures to fund these stages of its
business plan to the extent such is necessary.  Based on the Company's current
liquidity situation and in spite of statements to the effect that the Company
will more than likely need additional funding to carry out or implement its plan
of operation, the Company has a commitment from its officers and directors to
advance it sufficient working capital necessary to keep it current in its
reporting obligations over the next three years without having to pursue
additional financing or the raising of additional capital.

The Company's goal and ultimate objective is to generate recurring cash flow by
establishing long-term business opportunities.  The uncertainty of future
events, however, presently limits Anticline's ability to provide any assurances
regarding its ability to implement such a plan, raise financial resources, or
undertake these or any other business activities.

During the next twelve to eighteen months, the Company will actively seek out
and investigate possible business opportunities with the intent to acquire or
merge with one or more business ventures, all with a view towards further
exploring its mining claims, properties that the Company believes are valuable.
If and when funds are available for such purposes, management believes that
further exploration on the North Beck Claims may be warranted.

No commercial quantities of silver or gold have been discovered on the North
Beck Claims sufficient to implement any development program.  If funds become
available and the Company can initiate an exploration program, the Company will
be in a better position to determinate the commercial viability, if any, of the
North Beck Claims.

The Company does NOT have sufficient other funds of its own to finance
exploration costs, or to make capital improvements to its properties and
operating facilities.

Should the Company be unable to raise a significant amount of additional working
capital over the next three years, it more than likely would NOT have sufficient
funds, or access to sufficient funds, for exploration work.  As a result,
Anticline's plan of operation depends largely on its ability to cultivate
financial resources and business arrangements with investors and larger and
better-capitalized mining or exploration companies.

The Company does not intend to use or hire any employees, with the possible
exception of part-time clerical assistance on an as-needed basis.  The services
of outside advisors or consultants may be used if they can be obtained for
minimal cost or on a deferred payment basis.  Management is confident that it
will be able to operate in this manner and to continue its search for business
opportunities and arrangements during at least the next three years.

The Company's business plan will be directed primarily toward seeking out
business opportunities and also pursuing the eventual and possible exploration
of its patented mining claims.  The mineral interests and rights with respect to
these claims are believed to represent durable value for exploration.

Item 3.  Controls and Procedures

The Company maintains controls and procedures designed to ensure that the
information required to be disclosed in the reports that the Company files or
submits under the Securities Exchange Act of 1934 is recorded, processed,
summarized and reported within the time periods specified in the rules and forms
of the Securities and Exchange Commission.  Based upon their evaluation of those
controls and procedures performed within 90 days of the filing date of this
report, the Company's chief executive officer and the principal financial
officer (or persons performing similar functions) concluded that the Company's
disclosure controls and procedures were adequate.  As a result of its
evaluation, the Company has made no significant changes in its internal controls
or other factors that could significantly affect the controls and other
procedures already in place.



PART II - OTHER INFORMATION

Item 5.  Other information.

           None.

Item 6.  Exhibits and Reports on Form 8-K.

    (a)  Exhibits

     None.  All Sarbanes-Oxley certifications are after the signature
     line at the end of this document.

     (b)  Reports on Form 8-K

          None.

                              SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the Issuer has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.


                        ANTICLINE URANIUM, INC.
                               (Issuer)


Dated:  May 14, 2003
                                  /s/ John Michael Coombs
                                  ---------------------------------
                                  By:     John Michael Coombs
                                  Its:    Chairman of the Board
                                  Dated:  May 2, 2003


     Pursuant  to the requirements of the Securities Exchange  Act  of
1934,  as  amended,  this Report has also been  signed  below  by  the
following person on behalf of the Registrant and in the capacities and
on the dates indicated.

Dated:  May 14, 2003

                                  /s/ John Michael Coombs
                                  ---------------------------------
                                  By:     John Michael Coombs
                                  Its:    President, Chief Executive
                                           Officer and
                                           CFO (Principal Accounting and
                                           Financial Officer)


                                        10


                    CERTIFICATION PURSUANT TO
             SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

  I, John Michael Coombs, Chairman of the Board, President, Chief
Executive Officer, and CFO (Principal Accounting and Financial
Officer) of Anticline Uranium, Inc. (the "Registrant"), certify that:

     1.   I have reviewed this Quarterly Report on Form 10-QSB of the
Registrant;

     2.   Based on my knowledge, this Quarterly Report does not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this Quarterly Report;

     3.   Based on my knowledge, the financial statements, and other
financial information included in this Quarterly Report, fairly
present in all material respects the financial condition, results of
operations and cash flows of the Registrant as of, and for, the
periods presented in this Quarterly Report;

     4.   As the Registrant's certifying officer, I am responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant
and I have:

     a)   designed such disclosure controls and procedures to ensure
          that material information relating to the Registrant, including
          any consolidated subsidiary, is made known to me by others
          within those entities, particularly during the period in which this
          Quarterly Report is being prepared;

     b)   evaluated the effectiveness of the Registrant's disclosure
          controls and procedures as of a date within 90 days prior to the
          filing date of this Quarterly Report (the "Evaluation
          Date"); and

     c)   presented in this Quarterly Report, the Registrant's
          conclusions about the effectiveness of the disclosure
          controls and procedures based on our evaluation as of the
          Evaluation Date;

     5.   As the Registrant's certifying officer, I have disclosed,
based on our most recent evaluation, to the Registrant's auditors and
the audit committee of Registrant's board of directors (or persons
performing the equivalent function):


                                        11

     a)   all significant deficiencies in the design or operation of
          internal controls which could adversely affect the
          Registrant's ability to record, process, summarize and report
          financial data and have identified for the Registrant's auditors any
          material weaknesses in internal controls; and

     b)   any fraud, whether or not material, that involves management
          or other employees who have a significant role in the
          Registrant's internal controls; and

     6.   As the Registrant's certifying officer, I have indicated in this
Quarterly Report whether or not there were significant changes in
internal controls or in other factors that could significantly affect
internal controls subsequent to the date of our most recent
evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.


Dated: May 14, 2003                    /s/ John Michael Coombs
                                      -------------------------------
                                       John Michael Coombs,
                                       CEO, President, CFO, and
                                       Chairman of the Board


                       CERTIFICATION PURSUANT TO
             SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

  I, Terry Pantelakis, Secretary/Treasurer and a director of Anticline
Uranium, Inc. (the "Registrant"), certify that:

     1.   I have reviewed this Quarterly Report on Form 10-QSB of the
Registrant;

     2.   Based on my knowledge, this Quarterly Report does not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this Quarterly Report;

     3.   Based on my knowledge, the financial statements, and other
financial information included in this Quarterly Report, fairly
present in all material respects the financial condition, results of
operations and cash flows of the Registrant as of, and for, the
periods presented in this Quarterly Report;

     4.   The Registrant's other certifying officer and me are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for
the Registrant and we have:

     a)   designed such disclosure controls and procedures to ensure
          that material information relating to the Registrant, including
          its consolidated subsidiaries, is made known to us by others
          within those entities, particularly during the period in which this
          Quarterly Report is being prepared;

     b)   evaluated the effectiveness of the Registrant's disclosure
          controls and procedures as of a date within 90 days prior to
          the filing date of this Quarterly Report (the "Evaluation
          Date"); and

                                        12

     c)   presented in this Quarterly Report our conclusions about the
          effectiveness of the disclosure controls and procedures
          based on our evaluation as of the Evaluation Date;

     5.   The Registrant's other certifying officer and I have
disclosed, based on our most recent evaluation, to the Registrant's
auditors and the audit committee of Registrant's board of directors
(or persons performing the equivalent function):

     a)   all significant deficiencies in the design or operation of
          internal controls which could adversely affect the
          Registrant's ability to record, process, summarize and report
          financial data and have identified for the Registrant's auditors any
          material weaknesses in internal controls; and

     b)   any fraud, whether or not material, that involves management
          or other employees who have a significant role in the
          Registrant's internal controls; and

     6.   The Registrant's other certifying officer and I have
indicated in this Quarterly Report whether or not there were
significant changes in internal controls or in other factors that
could significantly affect internal controls subsequent to the date of
our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.



Dated: May 14, 2003            Signature:   /s/ Terry Pantelakis
                                           ---------------------
                                           Terry Pantelakis
                                           Secretary/Treasurer and
                                            director



                       CERTIFICATION PURSUANT TO
                        18 U.S.C. SECTION 1350,
                        AS ADOPTED PURSUANT TO
             SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report of Anticline Uranium,
Inc. (the "Registrant") on Form 10-QSB for the quarter ended March 31,
2003, as filed with the Securities and Exchange Commission on the date
hereof (the "Quarterly Report"), we, John Michael Coombs, CEO,
President, and Chairman of the Board of the Registrant, and Terry
Pantelakis, Secretary/Treasurer and a director of the Registrant,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of
our knowledge and belief:

     (1) The Quarterly Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Quarterly Report fairly
presents, in all material respects, the financial condition and result
of operations of the
Registrant.


                                        13


Dated: May 14, 2003                       /s/ John Michael Coombs
                                         -----------------------------
                                         John Michael Coombs,
                                          CEO, President, CFO, and
                                          Chairman of the Board


                                          /s/ Terry Pantelakis
Dated:  May 14, 2003                     -----------------------------
                                         Terry Pantelakis
                                          Secretary/Treasurer and
                                          director


                                        14